Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.
Ruggiero
Salvatore L
SL
Division of Oral and Maxillofacial Surgery, Long Island Jewish Medical Center, New Hyde Park, NY 11040, USA. ruggiero@lij.edu
Fantasia
John
J
Carlson
Eric
E
D000284:Administration, Oral; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D016723:Bone Remodeling / Q000187:drug effects; D001943:Breast Neoplasms / Q000188:drug therapy; D002985:Clinical Protocols; D003937:Diagnosis, Differential; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007571:Jaw Diseases / Q000139:chemically induced* / Q000473:pathology / Q000517:prevention & control; D009101:Multiple Myeloma / Q000188:drug therapy; D019647:Oral Surgical Procedures / Q000009:adverse effects; D010010:Osteoclasts / Q000187:drug effects; D010020:Osteonecrosis / Q000139:chemically induced* / Q000473:pathology / Q000517:prevention & control; D010024:Osteoporosis / Q000517:prevention & control; D012307:Risk Factors
D050071:Bone Density Conservation Agents; D004164:Diphosphonates